The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma.
 
Somnath Mukherjee
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Chris Hurt
No Relationships to Disclose
 
Sarah Gwynne
Honoraria - Celgene
 
Andrew Bateman
No Relationships to Disclose
 
Simon Gollins
No Relationships to Disclose
 
Ganesh Radhakrishna
No Relationships to Disclose
 
Jo Canham
No Relationships to Disclose
 
Ruby Ray
No Relationships to Disclose
 
Heike I Grabsch
No Relationships to Disclose
 
Ricky A. Sharma
Honoraria - Biocompatibles; Roche; Sirtex Medical
Consulting or Advisory Role - Biocompatibles; Cancer Research Technology; Sirtex Medical; Vertex
Research Funding - Sirtex Medical
Travel, Accommodations, Expenses - Biocompatibles; Sirtex Medical; Vertex
 
Rhydian Maggs
Travel, Accommodations, Expenses - Varian Medical Systems
 
Maria A Hawkins
No Relationships to Disclose
 
David Sebag-Montefiore
No Relationships to Disclose
 
Tim Maughan
Consulting or Advisory Role - Vertex
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
 
Gareth Griffiths
Consulting or Advisory Role - GlaxoSmithKline; Sirtex Medical
 
Tom David Lewis Crosby
Honoraria - Lilly